BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 23302743)

  • 61. Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.
    Du Y; Qi J; Lu Y; Wu J; Yoo D; Liu X; Zhang X; Li J; Sun W; Cong X; Shi J; Wang J
    Virus Genes; 2012 Dec; 45(3):474-87. PubMed ID: 22843314
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immune response to PCV2 vaccination in PRRSV viraemic piglets.
    Canelli E; Borghetti P; Ferrari L; De Angelis E; Ferrarini G; Catella A; Ogno G; Martelli P
    Vet Rec; 2016 Feb; 178(8):193. PubMed ID: 26829964
    [No Abstract]   [Full Text] [Related]  

  • 63. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of a major quantitative trait locus for porcine reproductive and respiratory syndrome (PRRS) resistance on response to coinfection with PRRS virus and porcine circovirus type 2b (PCV2b) in commercial pigs, with or without prior vaccination for PRRS.
    Dunkelberger JR; Serão NV; Niederwerder MC; Kerrigan MA; Lunney JK; Rowland RR; Dekkers JC
    J Anim Sci; 2017 Feb; 95(2):584-598. PubMed ID: 28380604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs.
    Steiner E; Balmelli C; Gerber H; Summerfield A; McCullough K
    BMC Vet Res; 2009 Dec; 5():45. PubMed ID: 20028550
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of maternal antibodies on efficacy of porcine circovirus type 2 (PCV2) vaccination to protect pigs from experimental infection with PCV2.
    Opriessnig T; Patterson AR; Elsener J; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2008 Mar; 15(3):397-401. PubMed ID: 18094109
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
    Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
    J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs naturally exposed to a heterologous European (Italian cluster) field strain: Clinical protection and cell-mediated immunity.
    Martelli P; Gozio S; Ferrari L; Rosina S; De Angelis E; Quintavalla C; Bottarelli E; Borghetti P
    Vaccine; 2009 Jun; 27(28):3788-99. PubMed ID: 19442420
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae.
    Chae C
    Vet J; 2016 Jun; 212():1-6. PubMed ID: 27256017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
    Zanotti C; Martinelli N; Lelli D; Amadori M
    Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Markedly different immune responses and virus kinetics in littermates infected with porcine circovirus type 2 or porcine parvovirus type 1.
    Opriessnig T; Gerber PF; Matzinger SR; Meng XJ; Halbur PG
    Vet Immunol Immunopathol; 2017 Sep; 191():51-59. PubMed ID: 28895867
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
    Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
    BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Commercial PCV2a-based vaccines are effective in protecting naturally PCV2b-infected finisher pigs against experimental challenge with a 2012 mutant PCV2.
    Opriessnig T; Gerber PF; Xiao CT; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2014 Jul; 32(34):4342-8. PubMed ID: 24929119
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PCV2 vaccination induces IFN-γ/TNF-α co-producing T cells with a potential role in protection.
    Koinig HC; Talker SC; Stadler M; Ladinig A; Graage R; Ritzmann M; Hennig-Pauka I; Gerner W; Saalmüller A
    Vet Res; 2015 Mar; 46():20. PubMed ID: 25888899
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.
    Fachinger V; Bischoff R; Jedidia SB; Saalmüller A; Elbers K
    Vaccine; 2008 Mar; 26(11):1488-99. PubMed ID: 18304705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Studies on porcine circovirus type 2 vaccination of 5-day-old piglets.
    O'Neill KC; Shen HG; Lin K; Hemann M; Beach NM; Meng XJ; Halbur PG; Opriessnig T
    Clin Vaccine Immunol; 2011 Nov; 18(11):1865-71. PubMed ID: 21940407
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of immune responses to porcine reproductive and respiratory syndrome virus in pigs during early stage of infection under farm conditions.
    Dwivedi V; Manickam C; Binjawadagi B; Linhares D; Murtaugh MP; Renukaradhya GJ
    Virol J; 2012 Feb; 9():45. PubMed ID: 22340040
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of vaccination against Porcine reproductive and respiratory syndrome virus (PRRSV) on the Porcine circovirus-2 (PCV-2) load in porcine circovirus associated disease (PCVAD) affected pigs.
    Genzow M; Schwartz K; Gonzalez G; Anderson G; Chittick W
    Can J Vet Res; 2009 Apr; 73(2):87-90. PubMed ID: 19436588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.